HeberFERON®
Combined interferon therapy for severe psoriasis and chronic hepatitis.
Product information
Combined interferon (alpha-2b + gamma) therapy. Developed by CIGB.
Indications
Severe plaque psoriasis and chronic hepatitis B/C.
Formulation
Injectable combination of recombinant interferon alpha-2b and gamma.
Administration
Subcutaneous injection, as prescribed by specialist.
Precautions
Monitor for flu-like symptoms, cytopenias and hepatic function. Contraindicated in decompensated cirrhosis.
Product information
- Manufacturer
- CIGB, Havana
- Regulatory status
- Registered in Cuba
Cancer & Oncology
CIMAvax-EGF®
Therapeutic vaccine targeting the EGF pathway for non-small cell lung cancer — registered in multiple countries.
VAXIRA® (Racotumomab)
Monoclonal antibody vaccine targeting NeuGcGM3 ganglioside antigens expressed on lung tumors.
HEBERSaVax®
Cuban biotech oncology product under investigation for cancer immunotherapy.